As a pharmaceutical manufacturer with high and new technology, Beijing Zizhu Pharmaceutical Co., Ltd was evolved in 2000 from Beijing 3rd Pharmaceutical Factory that has more than 30 years of history. Integrated with product development, manufacture, and trade, the corporation has 5 GMP production workshops, quality control center, R&D center, staff training center and other organizations. Located at Chaoyang North Rd. of Chaoyang District, The headquarters of the corporation has an area of 122 thousand square meters, with a construction area of 60 thousand square meters and 40% coverage of green land. The corporation has a registered capital of RMB 380,639,600, a staff team of more than 1,300 , and a total capital of 675 million RMB. In 1999, the corporation was the first one across the country that obtained the national GMP authentication in one time with 8 types of medicine, which are tablets, capsules, injection, powder injection, sustained-release capsule, gels, transdermal patches, and APIs. In addition, the corporation obtained the ISO9001:2000 international quality management system authentication and ISO14001 environment management system authentication respectively in 2001 and 2002. 

Zizhu specializes in the development and manufacture of five series of products, which are family planning medicine, ophthalmic medicine, reproductive health medicine, biological products and health care products. Zizhu is now the designated development and manufacture center of medicine for family planning and reproductive health, as well as the designated national manufacturer for contraceptives. As a fact, Zizhu has achieved the scale predominance on the development and manufacture of medicine for family planning and reproductive health, gaining considerable market share in China. For the time being, Zizhu has grown to be the biggest development center and manufacturer of medicine for family planning and reproductive health, as designated by the Family planning committee and SFDA. In addition, Zizhu has been listed as one of the famous enterprises in the reproductive medicine industry around the world, and has been approved by Beijing municipal government as the high-new technology enterprise in Beijing.

Zizhu has been paying much attention on the research and development of new products. Observing the development trend of domestic and oversea pharmaceutical research as well as the condition of the industry and competitors, the corporation determines the research and development strategy of its new products and plans the implementation, supported by its years of research on the steroid hormone, its high level industry platform, as well as its advanced GMP management. 

Through the implementation of three innovations on technology, management and mechanism respectively, Zizhu has fulfilled the rapid development of the enterprise. Supported by its scientific innovation, it has established the corporation relationship integrated with manufacture, study and research with some famous domestic and oversea research institutes and universities. It has formed its unique products development mechanism and products series, launching one or two new products every year that own high technology and are able to fill the market blank. Through the innovation on both management and system, the establishment of modern enterprise system, as well as the people-oriented modern management style, the corporation has achieved constant progress on its comprehensive economic performance in recent successive years. 

The corporation owns a fully owned affiliated marketing company, which is Beijing Zizhu-pharm Management Co., ltd.  plus several subsidary companies. It has shares in Beijing Novartis Pharma Ltd. and Beijing Hanmi Pharmaceutical Co. Ltd. 

Zizhu regards ?°Cherish life and promote health?± as its business policy for operation and development, as well as the holy mission assigned by the society. Zizhu will take enhancing the human health as its mission, and take ?°Quality oriented, Customer oriented; Credit oriented?± as its moral principles, making utmost efforts in providing quality products and service to customers and making outstanding contribution for the human health care.